logo
Select company
Select metric
2.72Current Ratio
VS
Market
66
Sector
43
Industry
31
History
78
$ 2.37Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information

Ticker

PLX

Company Name

PROTALIX BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PROTALIX BIOTHERAPEUTICS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLX - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 65.48M2.72$ 24.09M
3/31/2025$ 60.51M2.49$ 24.32M
12/31/2024$ 60.08M2.34$ 25.62M
9/30/2024$ 47.85M1.98$ 24.22M
6/30/2024$ 77.37M1.33$ 57.97M
3/31/2024$ 75.4M1.38$ 54.83M
12/31/2023$ 69.93M1.54$ 45.53M
9/30/2023$ 72.62M1.67$ 43.36M
6/30/2023$ 73.58M3.18$ 23.11M
3/31/2023$ 55.4M1.76$ 31.52M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Current Ratio stands at 1.37.
  • Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average Current Ratio has been 1.7.
  • The median Current Ratio for PROTALIX BIOTHERAPEUTICS INC during this period was 1.6
  • PROTALIX BIOTHERAPEUTICS INC reached its highest Current Ratio over the past 5 years at 3.18.
  • The lowest Current Ratio recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe 0.64

PROTALIX BIOTHERAPEUTICS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
CSBR : CHAMPIONS ONCOLOGY INC 0.93THTX : THERATECHNOLOGIES INC 0.84BDTX : BLACK DIAMOND THERAPEUTICS INC 8.73SPRO : SPERO THERAPEUTICS INC 3.97ENTA : ENANTA PHARMACEUTICALS INC 5CELU : CELULARITY INC 0.25IVVD : INVIVYD INC 1.33DOMH : DOMINARI HOLDINGS INC 3.65SGMO : SANGAMO THERAPEUTICS INC 1.05ALEC : ALECTOR INC 3.78

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: AssetsC [ $ 60.33M ] / LiabilitesC [ $ 43.9M ]
(=) Current Ratio [ 1.37 ]

PLX - Current Ratio, Last 5 years

0.64

Minimum

Dec 31, 2020

3.18

Maximum

Jun 30, 2023

1.7

Average

1.6

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44